4.7 Article

Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months

Related references

Note: Only part of the references are listed.
Review Gastroenterology & Hepatology

The Efficacy and Safety of Rifaximin for the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis

Stacy B. Menees et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)

Article Gastroenterology & Hepatology

Proton Pump Inhibitor Therapy Use Does Not Predispose to Small Intestinal Bacterial Overgrowth

Shiva K. Ratuapli et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)

Article Medicine, General & Internal

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation.

Mark Pimentel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Editorial Material Gastroenterology & Hepatology

Evaluating a Bacterial Hypothesis in IBS Using a Modification of Koch's Postulates: Part 1

Mark Pimentel

AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)

Article Gastroenterology & Hepatology

Increased Incidence of Small Intestinal Bacterial Overgrowth During Proton Pump Inhibitor Therapy

Lucio Lombardo et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)

Review Gastroenterology & Hepatology

Abnormal Breath Testing in IBS: A Meta-Analysis

Eric D. Shah et al.

DIGESTIVE DISEASES AND SCIENCES (2010)

Review Gastroenterology & Hepatology

Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis

Alexander C. Ford et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)

Editorial Material Gastroenterology & Hepatology

Bacterial Overgrowth and Irritable Bowel Syndrome: Unifying Hypothesis or a Spurious Consequence of Proton Pump Inhibitors?

Brennan M. R. Spiegel et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)

Review Gastroenterology & Hepatology

A systematic review of diagnostic tests for small intestinal bacterial overgrowth

Reza Khoshini et al.

DIGESTIVE DISEASES AND SCIENCES (2008)

Article Gastroenterology & Hepatology

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

Iris Posserud et al.

Article Medicine, General & Internal

Irritable bowel syndrome

N. J. Talley

INTERNAL MEDICINE JOURNAL (2006)

Article Gastroenterology & Hepatology

Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity

Mark Pimentel et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)

Article Gastroenterology & Hepatology

A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence

AI Sharara et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)

Review Economics

Costs of irritable bowel syndrome in the UK and US

S Maxion-Bergemann et al.

PHARMACOECONOMICS (2006)

Review Gastroenterology & Hepatology

Irritable bowel syndrome: Toward an understanding of severity

A Lembo et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)

Article Infectious Diseases

Rifaximin - a novel antimicrobial for enteric infections

DB Huang et al.

JOURNAL OF INFECTION (2005)

Article Nutrition & Dietetics

Effect of predominant methanogenic flora on the outcome of lactose breath test in irritable bowel syndrome patients

P Vernia et al.

EUROPEAN JOURNAL OF CLINICAL NUTRITION (2003)

Article Gastroenterology & Hepatology

The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects

APS Hungin et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)

Article Gastroenterology & Hepatology

Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

SA Müller-Lissner et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)